EIT Health New Models to Deliver Healthcare Call

EIT Health New Models to Deliver Healthcare Call

Offers research teams and institutions for EIT Health New Models to Deliver Healthcare in medical technology and artificial intelligence.

Eligibility · EU member states

⚠ This may reflect a past cycle — verify the current call on the funder's site.

EIT Health's New Models to Deliver Healthcare (NMDH) Call 2026 funded cross-border consortia implementing value-based care models using CE-marked health solutions at Innovation Maturity Level 8–9. Unlike the Innovation Validation Call, which supports development toward CE marking, NMDH exclusively targets solutions that are already regulatory-approved and market-ready — the grant funds real-world adoption and scaling into healthcare systems rather than development or clinical validation. EIT Health covered up to 50% of total project costs, with grants ranging from €400,000 (minimum for micro and small enterprises) to €700,000 (maximum per project). The 2026 call ran from 25 February to 6 May 2026 and is now closed; the next cycle is expected in 2027.

Eligibility is defined by consortium composition rather than company type. Mandatory consortium roles include: a commercialising entity holding the CE-marked device, a healthcare provider, a health economics partner, an IT integration partner, and a payer organisation. The consortium must span at least two countries and include representatives from at least two Knowledge Triangle sectors (industry, research, and education). Project duration is capped at 24 months. The 50% co-funding requirement means applicants must secure matching resources from consortium members, payers, or other sources before applying.

The NMDH instrument is well-suited to medtech and digital health companies that have cleared regulatory hurdles and need structured support — including reimbursement pathway development and health economics evidence generation — to achieve real-world uptake across European health systems. Scoring favours solutions with documented patient impact and a credible route to payer-adoption at scale. Applicants for future cycles should focus proposal development on value-based care evidence, interoperability with existing health IT systems, and the strength of payer partnerships within the consortium.